Chongqing Sintaho Pharmaceutical Co., Ltd.
Overview
Chongqing Sintaho Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Chongqing, China, founded in 2016, with 201-500 employees.
Active pharmaceutical ingredients supplied
Substances Chongqing Sintaho Pharmaceutical Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Chongqing Sintaho Pharmaceutical Co., Ltd. holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- TRABECTEDINActive2026-05-15
- LURBINECTEDINActive2026-03-31
- PEMETREXED DISODIUM HEPTAHYDRATEActive2025-11-05
- SEMAGLUTIDEActive2025-06-23
- CARFILZOMIBActive2025-03-11
- TIRBANIBULINActive2024-03-19
- ERIBULIN MESYLATEActive2023-01-31
- DOCETAXELActive2022-06-27
- PACLITAXEL (SEMI-SYNTHETIC)Active2021-11-18
- AZACITIDINE USPActive2014-03-12
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Chongqing Sintaho Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Chongqing Sintaho Pharmaceutical Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.